Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Extracorporeal Membrane Oxygenation | 151 | 2024 | 1452 | 19.100 |
Why?
|
Cardiopulmonary Resuscitation | 41 | 2024 | 985 | 5.990 |
Why?
|
Cardiac Surgical Procedures | 52 | 2023 | 3603 | 3.860 |
Why?
|
Heart Defects, Congenital | 58 | 2024 | 4673 | 3.580 |
Why?
|
Heart Arrest | 27 | 2024 | 1494 | 3.150 |
Why?
|
Heart Diseases | 22 | 2024 | 2782 | 2.180 |
Why?
|
Hypoplastic Left Heart Syndrome | 14 | 2016 | 594 | 2.020 |
Why?
|
Intensive Care Units, Pediatric | 29 | 2024 | 1014 | 1.920 |
Why?
|
Registries | 53 | 2024 | 8175 | 1.920 |
Why?
|
Hospital Mortality | 48 | 2024 | 5272 | 1.910 |
Why?
|
Cardiopulmonary Bypass | 13 | 2022 | 1093 | 1.860 |
Why?
|
Infant, Newborn | 117 | 2024 | 26183 | 1.670 |
Why?
|
Respiratory Insufficiency | 18 | 2023 | 1230 | 1.670 |
Why?
|
Postoperative Care | 10 | 2019 | 1471 | 1.620 |
Why?
|
Child | 148 | 2024 | 79818 | 1.370 |
Why?
|
Infant | 122 | 2024 | 36055 | 1.310 |
Why?
|
Heart Transplantation | 20 | 2021 | 3220 | 1.150 |
Why?
|
Retrospective Studies | 136 | 2024 | 80168 | 1.070 |
Why?
|
Fontan Procedure | 11 | 2016 | 791 | 1.070 |
Why?
|
Child, Preschool | 94 | 2024 | 42062 | 1.030 |
Why?
|
Respiration, Artificial | 21 | 2022 | 2618 | 0.970 |
Why?
|
Myocarditis | 6 | 2023 | 766 | 0.920 |
Why?
|
Lung Transplantation | 3 | 2022 | 1305 | 0.890 |
Why?
|
Life Support Care | 3 | 2018 | 221 | 0.850 |
Why?
|
Fraud | 1 | 2023 | 66 | 0.840 |
Why?
|
Humans | 271 | 2024 | 758406 | 0.780 |
Why?
|
Coronary Care Units | 4 | 2020 | 235 | 0.760 |
Why?
|
Heart Failure | 21 | 2023 | 11593 | 0.750 |
Why?
|
Intensive Care Units | 7 | 2023 | 3732 | 0.740 |
Why?
|
Critical Illness | 10 | 2024 | 2703 | 0.730 |
Why?
|
Catheterization, Peripheral | 3 | 2019 | 340 | 0.720 |
Why?
|
Catheterization, Central Venous | 4 | 2019 | 526 | 0.720 |
Why?
|
Erythrocyte Transfusion | 2 | 2018 | 563 | 0.700 |
Why?
|
Heart Ventricles | 11 | 2017 | 3806 | 0.700 |
Why?
|
Critical Care | 12 | 2023 | 2692 | 0.690 |
Why?
|
Treatment Outcome | 73 | 2024 | 64378 | 0.660 |
Why?
|
Heart-Assist Devices | 10 | 2021 | 1279 | 0.630 |
Why?
|
Risk Adjustment | 3 | 2019 | 600 | 0.620 |
Why?
|
Waiting Lists | 8 | 2015 | 762 | 0.620 |
Why?
|
Norwood Procedures | 3 | 2022 | 192 | 0.600 |
Why?
|
Developmental Disabilities | 2 | 2019 | 1504 | 0.590 |
Why?
|
Postoperative Complications | 23 | 2019 | 15637 | 0.580 |
Why?
|
Cardiovascular Surgical Procedures | 5 | 2019 | 190 | 0.580 |
Why?
|
Male | 139 | 2024 | 358747 | 0.580 |
Why?
|
Hemorrhage | 9 | 2022 | 3400 | 0.570 |
Why?
|
Healthcare Disparities | 3 | 2024 | 3364 | 0.560 |
Why?
|
Palliative Care | 12 | 2016 | 3570 | 0.550 |
Why?
|
Extracorporeal Circulation | 3 | 2017 | 182 | 0.550 |
Why?
|
Female | 143 | 2024 | 390323 | 0.540 |
Why?
|
Logistic Models | 25 | 2023 | 13276 | 0.540 |
Why?
|
Cardiotonic Agents | 3 | 2016 | 539 | 0.540 |
Why?
|
Brain Diseases | 3 | 2017 | 1541 | 0.540 |
Why?
|
Catheterization | 5 | 2023 | 1426 | 0.530 |
Why?
|
Hemolysis | 3 | 2013 | 423 | 0.530 |
Why?
|
Hospitals, Pediatric | 10 | 2019 | 1854 | 0.510 |
Why?
|
Oxygenators, Membrane | 2 | 2012 | 56 | 0.510 |
Why?
|
Shock, Cardiogenic | 3 | 2022 | 707 | 0.490 |
Why?
|
Transposition of Great Vessels | 2 | 2021 | 590 | 0.490 |
Why?
|
Adolescent | 62 | 2024 | 87892 | 0.470 |
Why?
|
Ultrafiltration | 1 | 2014 | 49 | 0.470 |
Why?
|
Brain Infarction | 2 | 2014 | 290 | 0.470 |
Why?
|
Time Factors | 36 | 2022 | 39872 | 0.460 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2016 | 261 | 0.460 |
Why?
|
Risk Factors | 50 | 2023 | 73809 | 0.440 |
Why?
|
Operative Blood Salvage | 1 | 2013 | 8 | 0.440 |
Why?
|
Length of Stay | 13 | 2019 | 6439 | 0.420 |
Why?
|
Pulmonary Artery | 7 | 2019 | 1915 | 0.420 |
Why?
|
Intensive Care, Neonatal | 1 | 2014 | 197 | 0.420 |
Why?
|
Intracranial Hemorrhages | 4 | 2020 | 820 | 0.420 |
Why?
|
Blood Transfusion, Autologous | 1 | 2013 | 131 | 0.410 |
Why?
|
Bed Occupancy | 1 | 2012 | 38 | 0.400 |
Why?
|
Central Nervous System Diseases | 1 | 2016 | 520 | 0.400 |
Why?
|
Survival Analysis | 18 | 2017 | 10112 | 0.400 |
Why?
|
Muscle Stretching Exercises | 1 | 2012 | 36 | 0.390 |
Why?
|
Early Ambulation | 1 | 2012 | 47 | 0.390 |
Why?
|
Postoperative Period | 8 | 2018 | 1812 | 0.380 |
Why?
|
Anticoagulants | 10 | 2024 | 4777 | 0.380 |
Why?
|
Seizures | 5 | 2023 | 2919 | 0.380 |
Why?
|
Gestational Age | 5 | 2014 | 3565 | 0.370 |
Why?
|
Hospitals | 6 | 2024 | 3887 | 0.370 |
Why?
|
Brain Injuries | 3 | 2020 | 2044 | 0.370 |
Why?
|
Hypertension, Pulmonary | 4 | 2020 | 1564 | 0.370 |
Why?
|
Vasoconstrictor Agents | 1 | 2014 | 651 | 0.360 |
Why?
|
Thrombosis | 7 | 2022 | 2929 | 0.350 |
Why?
|
Intensive Care Units, Neonatal | 5 | 2022 | 833 | 0.340 |
Why?
|
Out-of-Hospital Cardiac Arrest | 3 | 2024 | 327 | 0.340 |
Why?
|
Carotid Arteries | 1 | 2014 | 939 | 0.340 |
Why?
|
Perioperative Period | 1 | 2011 | 262 | 0.340 |
Why?
|
Hemodynamics | 12 | 2021 | 4159 | 0.330 |
Why?
|
Hospital Costs | 1 | 2015 | 960 | 0.330 |
Why?
|
Vasodilator Agents | 3 | 2018 | 973 | 0.330 |
Why?
|
Multiple Organ Failure | 2 | 2022 | 385 | 0.330 |
Why?
|
Primary Graft Dysfunction | 2 | 2021 | 111 | 0.320 |
Why?
|
Blalock-Taussig Procedure | 3 | 2022 | 60 | 0.320 |
Why?
|
Platelet Aggregation | 1 | 2012 | 773 | 0.320 |
Why?
|
Plasma Substitutes | 1 | 2008 | 57 | 0.320 |
Why?
|
Muscular Atrophy | 1 | 2012 | 327 | 0.320 |
Why?
|
Risk Assessment | 17 | 2023 | 23884 | 0.320 |
Why?
|
Biomedical Research | 2 | 2024 | 3418 | 0.310 |
Why?
|
Survival Rate | 21 | 2021 | 12721 | 0.310 |
Why?
|
Infant, Premature, Diseases | 1 | 2014 | 708 | 0.300 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 3 | 2022 | 577 | 0.300 |
Why?
|
Physical Therapy Modalities | 1 | 2012 | 536 | 0.300 |
Why?
|
Brain Death | 5 | 2023 | 356 | 0.300 |
Why?
|
Multivariate Analysis | 14 | 2019 | 12096 | 0.290 |
Why?
|
Severity of Illness Index | 13 | 2021 | 15785 | 0.290 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2023 | 818 | 0.290 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2011 | 447 | 0.290 |
Why?
|
Attention | 1 | 2017 | 2387 | 0.280 |
Why?
|
Infant Mortality | 2 | 2012 | 757 | 0.280 |
Why?
|
Odds Ratio | 9 | 2020 | 9650 | 0.280 |
Why?
|
Tissue and Organ Procurement | 3 | 2011 | 943 | 0.280 |
Why?
|
Acute Kidney Injury | 6 | 2019 | 1926 | 0.270 |
Why?
|
Propensity Score | 2 | 2015 | 1907 | 0.270 |
Why?
|
United States | 28 | 2024 | 72136 | 0.260 |
Why?
|
Myocardial Contraction | 2 | 2016 | 1516 | 0.260 |
Why?
|
Program Development | 2 | 2011 | 1298 | 0.260 |
Why?
|
Body Weight | 2 | 2014 | 4603 | 0.250 |
Why?
|
Critical Pathways | 1 | 2009 | 473 | 0.250 |
Why?
|
Intubation, Intratracheal | 5 | 2016 | 1327 | 0.250 |
Why?
|
Decompression, Surgical | 3 | 2023 | 604 | 0.240 |
Why?
|
Carbon Dioxide | 4 | 2023 | 1146 | 0.240 |
Why?
|
Work of Breathing | 1 | 2004 | 56 | 0.240 |
Why?
|
Atrial Fibrillation | 2 | 2022 | 5103 | 0.230 |
Why?
|
Arrhythmias, Cardiac | 5 | 2023 | 2248 | 0.230 |
Why?
|
Pulmonary Edema | 1 | 2007 | 408 | 0.230 |
Why?
|
Resuscitation | 1 | 2008 | 661 | 0.230 |
Why?
|
Inhalation | 1 | 2004 | 143 | 0.230 |
Why?
|
Heart | 3 | 2024 | 4382 | 0.230 |
Why?
|
Survival | 2 | 2018 | 160 | 0.230 |
Why?
|
Databases, Factual | 10 | 2021 | 7980 | 0.220 |
Why?
|
Cohort Studies | 21 | 2022 | 41256 | 0.220 |
Why?
|
Age Factors | 14 | 2021 | 18358 | 0.220 |
Why?
|
Heart Atria | 3 | 2023 | 1344 | 0.220 |
Why?
|
Enteral Nutrition | 1 | 2009 | 785 | 0.220 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2005 | 227 | 0.210 |
Why?
|
Liver Failure, Acute | 1 | 2024 | 181 | 0.210 |
Why?
|
Nervous System Diseases | 1 | 2013 | 1647 | 0.210 |
Why?
|
Integrin alpha2 | 1 | 2022 | 39 | 0.210 |
Why?
|
Chi-Square Distribution | 7 | 2016 | 3425 | 0.210 |
Why?
|
American Heart Association | 3 | 2022 | 1039 | 0.200 |
Why?
|
Hypnotics and Sedatives | 3 | 2020 | 1176 | 0.200 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5649 | 0.200 |
Why?
|
Integrin beta3 | 1 | 2022 | 120 | 0.200 |
Why?
|
Peritoneal Dialysis | 2 | 2013 | 157 | 0.200 |
Why?
|
Pediatrics | 5 | 2022 | 3587 | 0.200 |
Why?
|
Safety Management | 1 | 2007 | 760 | 0.190 |
Why?
|
Adult | 39 | 2024 | 219935 | 0.190 |
Why?
|
Child Development | 1 | 2013 | 2285 | 0.190 |
Why?
|
Attitude to Death | 2 | 2014 | 400 | 0.190 |
Why?
|
Renal Insufficiency | 3 | 2013 | 809 | 0.190 |
Why?
|
Liver Transplantation | 2 | 2024 | 2325 | 0.190 |
Why?
|
Clinical Competence | 6 | 2013 | 4775 | 0.190 |
Why?
|
Practice Guidelines as Topic | 4 | 2021 | 7378 | 0.190 |
Why?
|
Cross-Sectional Studies | 11 | 2024 | 25956 | 0.180 |
Why?
|
Delphi Technique | 1 | 2024 | 829 | 0.180 |
Why?
|
Atrial Septum | 1 | 2021 | 60 | 0.180 |
Why?
|
Cardiomyopathies | 2 | 2017 | 1944 | 0.180 |
Why?
|
Social Responsibility | 1 | 2023 | 386 | 0.180 |
Why?
|
Truncus Arteriosus | 1 | 2020 | 22 | 0.180 |
Why?
|
Parents | 3 | 2024 | 3548 | 0.180 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2023 | 269 | 0.180 |
Why?
|
Heart Block | 2 | 2016 | 392 | 0.170 |
Why?
|
Peer Review, Research | 1 | 2023 | 340 | 0.170 |
Why?
|
Fluid Therapy | 2 | 2021 | 578 | 0.170 |
Why?
|
Ventilator Weaning | 2 | 2018 | 161 | 0.170 |
Why?
|
Influenza, Human | 1 | 2011 | 1516 | 0.170 |
Why?
|
Models, Theoretical | 1 | 2012 | 3561 | 0.170 |
Why?
|
Partial Pressure | 2 | 2023 | 245 | 0.170 |
Why?
|
Preoperative Care | 4 | 2015 | 2249 | 0.170 |
Why?
|
Hemoptysis | 1 | 2021 | 152 | 0.170 |
Why?
|
Hemophilia A | 1 | 2003 | 359 | 0.170 |
Why?
|
Milrinone | 2 | 2016 | 86 | 0.170 |
Why?
|
Vascular Surgical Procedures | 1 | 2008 | 1470 | 0.170 |
Why?
|
Term Birth | 2 | 2017 | 140 | 0.160 |
Why?
|
Statistics, Nonparametric | 9 | 2017 | 2850 | 0.160 |
Why?
|
Medical Errors | 1 | 2007 | 1255 | 0.160 |
Why?
|
Hemostatics | 1 | 2021 | 242 | 0.160 |
Why?
|
Adsorption | 1 | 2019 | 197 | 0.160 |
Why?
|
Hypothermia, Induced | 1 | 2024 | 756 | 0.160 |
Why?
|
Boston | 9 | 2018 | 9304 | 0.160 |
Why?
|
Consensus | 3 | 2024 | 3099 | 0.150 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2008 | 1426 | 0.150 |
Why?
|
Cooperative Behavior | 2 | 2016 | 1501 | 0.150 |
Why?
|
Hospitalization | 3 | 2023 | 10652 | 0.150 |
Why?
|
Societies, Medical | 4 | 2019 | 3891 | 0.150 |
Why?
|
End Stage Liver Disease | 1 | 2022 | 352 | 0.150 |
Why?
|
Phlebotomy | 1 | 2018 | 137 | 0.150 |
Why?
|
Blood Transfusion | 1 | 2024 | 1321 | 0.150 |
Why?
|
Sternotomy | 1 | 2018 | 128 | 0.140 |
Why?
|
Minority Groups | 2 | 2023 | 1206 | 0.140 |
Why?
|
Selectins | 1 | 1997 | 101 | 0.140 |
Why?
|
Quality of Life | 3 | 2014 | 13285 | 0.140 |
Why?
|
Follow-Up Studies | 18 | 2019 | 39059 | 0.140 |
Why?
|
Pulmonary Gas Exchange | 2 | 2014 | 378 | 0.140 |
Why?
|
Quality Assurance, Health Care | 1 | 2007 | 2167 | 0.140 |
Why?
|
Phosphodiesterase 3 Inhibitors | 1 | 2016 | 11 | 0.140 |
Why?
|
Renal Replacement Therapy | 1 | 2019 | 281 | 0.140 |
Why?
|
Chylothorax | 2 | 2019 | 83 | 0.140 |
Why?
|
Tidal Volume | 2 | 2014 | 487 | 0.140 |
Why?
|
Drowning | 1 | 2016 | 26 | 0.130 |
Why?
|
Adrenergic beta-Agonists | 1 | 2018 | 344 | 0.130 |
Why?
|
Deep Sedation | 1 | 2017 | 118 | 0.130 |
Why?
|
Medical Staff, Hospital | 1 | 2020 | 600 | 0.130 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2017 | 172 | 0.130 |
Why?
|
Advanced Cardiac Life Support | 2 | 2014 | 78 | 0.130 |
Why?
|
Coronary Vessel Anomalies | 1 | 2019 | 308 | 0.130 |
Why?
|
Recovery of Function | 3 | 2012 | 2970 | 0.130 |
Why?
|
Aspartate Aminotransferases | 2 | 2010 | 415 | 0.130 |
Why?
|
Vascular Resistance | 4 | 2021 | 930 | 0.130 |
Why?
|
Assisted Circulation | 1 | 2015 | 100 | 0.130 |
Why?
|
Lactic Acid | 3 | 2023 | 1133 | 0.130 |
Why?
|
Goals | 1 | 2020 | 707 | 0.120 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2022 | 2747 | 0.120 |
Why?
|
Femoral Artery | 2 | 2022 | 824 | 0.120 |
Why?
|
Milk, Human | 1 | 2019 | 483 | 0.120 |
Why?
|
Water-Electrolyte Balance | 1 | 1996 | 325 | 0.120 |
Why?
|
Prospective Studies | 16 | 2022 | 54137 | 0.120 |
Why?
|
Shock, Septic | 1 | 2021 | 761 | 0.120 |
Why?
|
Epinephrine | 1 | 2018 | 790 | 0.120 |
Why?
|
Cell Adhesion Molecules | 2 | 1998 | 1600 | 0.120 |
Why?
|
Young Adult | 15 | 2024 | 58808 | 0.120 |
Why?
|
Vitamin K 1 | 1 | 2014 | 47 | 0.120 |
Why?
|
Cardiology Service, Hospital | 2 | 2020 | 239 | 0.110 |
Why?
|
Blood Gas Analysis | 1 | 2015 | 377 | 0.110 |
Why?
|
Standard of Care | 1 | 2018 | 550 | 0.110 |
Why?
|
Creatinine | 3 | 2011 | 1892 | 0.110 |
Why?
|
Hypopituitarism | 1 | 1996 | 250 | 0.110 |
Why?
|
Coronary Circulation | 3 | 2016 | 1561 | 0.110 |
Why?
|
Pulmonary Embolism | 2 | 2021 | 2540 | 0.110 |
Why?
|
Bereavement | 2 | 2014 | 307 | 0.110 |
Why?
|
Patient Discharge | 4 | 2021 | 3433 | 0.110 |
Why?
|
Qualitative Research | 1 | 2024 | 2976 | 0.110 |
Why?
|
Hyponatremia | 1 | 1996 | 279 | 0.110 |
Why?
|
Immune System Diseases | 1 | 2015 | 258 | 0.110 |
Why?
|
Ventilators, Mechanical | 2 | 2021 | 287 | 0.110 |
Why?
|
Oxygen Consumption | 2 | 2016 | 1845 | 0.110 |
Why?
|
Centrifugation | 1 | 2013 | 122 | 0.110 |
Why?
|
Motor Skills Disorders | 1 | 2013 | 89 | 0.110 |
Why?
|
Acute Disease | 3 | 2021 | 7225 | 0.100 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2014 | 506 | 0.100 |
Why?
|
HIV | 1 | 2020 | 1581 | 0.100 |
Why?
|
Terminally Ill | 1 | 2014 | 240 | 0.100 |
Why?
|
Fibrinolytic Agents | 1 | 2022 | 2071 | 0.100 |
Why?
|
Thrombolytic Therapy | 1 | 2021 | 2060 | 0.100 |
Why?
|
Superior Vena Cava Syndrome | 1 | 2013 | 56 | 0.100 |
Why?
|
Cerebral Infarction | 1 | 2017 | 981 | 0.100 |
Why?
|
Equipment Design | 3 | 2019 | 3507 | 0.100 |
Why?
|
Neoplasms | 2 | 2020 | 22032 | 0.100 |
Why?
|
Analgesics | 1 | 2019 | 1064 | 0.100 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1090 | 0.100 |
Why?
|
Quality Indicators, Health Care | 2 | 2012 | 1797 | 0.100 |
Why?
|
Proportional Hazards Models | 4 | 2016 | 12440 | 0.100 |
Why?
|
Middle Aged | 18 | 2024 | 219568 | 0.100 |
Why?
|
Language Development Disorders | 1 | 2013 | 192 | 0.100 |
Why?
|
Cardiac Output, Low | 2 | 2017 | 191 | 0.100 |
Why?
|
Quality Improvement | 3 | 2016 | 3806 | 0.100 |
Why?
|
Terminal Care | 2 | 2014 | 1750 | 0.090 |
Why?
|
Head | 1 | 2017 | 921 | 0.090 |
Why?
|
Proxy | 1 | 2012 | 148 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 5 | 2019 | 6493 | 0.090 |
Why?
|
Age Distribution | 1 | 2017 | 2882 | 0.090 |
Why?
|
ABO Blood-Group System | 2 | 2010 | 367 | 0.090 |
Why?
|
Immobilization | 1 | 2012 | 228 | 0.090 |
Why?
|
Myocardium | 2 | 2016 | 4690 | 0.090 |
Why?
|
Enterovirus | 1 | 2011 | 67 | 0.090 |
Why?
|
Graft Survival | 1 | 2021 | 3794 | 0.090 |
Why?
|
Enterovirus Infections | 1 | 2011 | 74 | 0.090 |
Why?
|
Congresses as Topic | 1 | 2015 | 799 | 0.090 |
Why?
|
Reperfusion Injury | 1 | 1997 | 1022 | 0.090 |
Why?
|
Physicians | 2 | 2022 | 4580 | 0.090 |
Why?
|
Cleft Lip | 1 | 1996 | 504 | 0.090 |
Why?
|
Benchmarking | 1 | 2017 | 1042 | 0.090 |
Why?
|
Partial Thromboplastin Time | 2 | 2021 | 203 | 0.090 |
Why?
|
Education, Medical, Continuing | 2 | 2019 | 827 | 0.090 |
Why?
|
Cleft Palate | 1 | 1996 | 587 | 0.090 |
Why?
|
Memory Disorders | 1 | 2017 | 1197 | 0.090 |
Why?
|
Catheters, Indwelling | 1 | 2012 | 428 | 0.090 |
Why?
|
Neurologic Examination | 1 | 2013 | 914 | 0.090 |
Why?
|
Child Mortality | 1 | 2012 | 205 | 0.090 |
Why?
|
Magnetics | 1 | 2013 | 600 | 0.090 |
Why?
|
Medical Audit | 1 | 2011 | 452 | 0.080 |
Why?
|
Lung Compliance | 2 | 2000 | 201 | 0.080 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2017 | 2497 | 0.080 |
Why?
|
Cerebrovascular Disorders | 1 | 2016 | 1475 | 0.080 |
Why?
|
Ventricular Function | 1 | 2011 | 406 | 0.080 |
Why?
|
Situs Inversus | 1 | 2009 | 63 | 0.080 |
Why?
|
Apgar Score | 1 | 2009 | 126 | 0.080 |
Why?
|
Leukocytes | 1 | 1997 | 2025 | 0.080 |
Why?
|
Incidence | 7 | 2021 | 21272 | 0.080 |
Why?
|
Cause of Death | 4 | 2019 | 3675 | 0.080 |
Why?
|
Aorta | 2 | 2014 | 2037 | 0.080 |
Why?
|
Histocompatibility | 1 | 2010 | 316 | 0.080 |
Why?
|
Prognosis | 9 | 2019 | 29557 | 0.080 |
Why?
|
Databases as Topic | 1 | 2011 | 472 | 0.080 |
Why?
|
Pacemaker, Artificial | 2 | 2005 | 808 | 0.080 |
Why?
|
Angioplasty, Balloon | 1 | 2013 | 588 | 0.080 |
Why?
|
Aorta, Thoracic | 1 | 2015 | 1094 | 0.080 |
Why?
|
Secondary Prevention | 1 | 2015 | 1474 | 0.080 |
Why?
|
Sex Factors | 2 | 2015 | 10504 | 0.080 |
Why?
|
Medical Oncology | 1 | 2020 | 2312 | 0.080 |
Why?
|
Linear Models | 1 | 2018 | 5862 | 0.080 |
Why?
|
Catheter-Related Infections | 1 | 2011 | 273 | 0.080 |
Why?
|
Confidence Intervals | 2 | 2013 | 2925 | 0.080 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2014 | 1111 | 0.070 |
Why?
|
Patient Simulation | 1 | 2010 | 297 | 0.070 |
Why?
|
Tricuspid Valve | 1 | 2010 | 408 | 0.070 |
Why?
|
Emergency Medical Services | 2 | 2017 | 1915 | 0.070 |
Why?
|
Education, Distance | 1 | 2011 | 259 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2018 | 2215 | 0.070 |
Why?
|
Learning | 1 | 2016 | 1739 | 0.070 |
Why?
|
Patient Selection | 3 | 2021 | 4244 | 0.070 |
Why?
|
Down Syndrome | 1 | 2015 | 892 | 0.070 |
Why?
|
Heparin | 2 | 2021 | 1632 | 0.070 |
Why?
|
Case-Control Studies | 3 | 2021 | 22029 | 0.070 |
Why?
|
Cardiac Output | 2 | 2021 | 837 | 0.070 |
Why?
|
Fenoldopam | 1 | 2006 | 6 | 0.070 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2010 | 664 | 0.070 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 7021 | 0.070 |
Why?
|
Device Removal | 1 | 2021 | 633 | 0.070 |
Why?
|
Neuromuscular Blockade | 2 | 2017 | 146 | 0.070 |
Why?
|
NF-kappa B | 1 | 2014 | 2472 | 0.060 |
Why?
|
Electroencephalography | 3 | 2020 | 6187 | 0.060 |
Why?
|
Educational Status | 1 | 2013 | 2513 | 0.060 |
Why?
|
Birth Weight | 1 | 2014 | 2097 | 0.060 |
Why?
|
Transportation of Patients | 1 | 2006 | 174 | 0.060 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2009 | 326 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2018 | 2476 | 0.060 |
Why?
|
Anesthesia | 2 | 2007 | 1582 | 0.060 |
Why?
|
Survivors | 2 | 2024 | 2370 | 0.060 |
Why?
|
Endothelium, Vascular | 1 | 1997 | 4429 | 0.060 |
Why?
|
Pulmonary Atresia | 1 | 2006 | 159 | 0.060 |
Why?
|
Infusions, Intravenous | 2 | 2015 | 2210 | 0.060 |
Why?
|
Ganglia, Spinal | 1 | 2007 | 523 | 0.060 |
Why?
|
Parenteral Nutrition | 1 | 2009 | 656 | 0.060 |
Why?
|
Ebstein Anomaly | 1 | 2005 | 101 | 0.060 |
Why?
|
Nerve Fibers | 1 | 2007 | 708 | 0.060 |
Why?
|
Foreign Bodies | 1 | 2008 | 397 | 0.060 |
Why?
|
Stroke | 2 | 2016 | 9694 | 0.060 |
Why?
|
Pregnancy | 4 | 2017 | 29742 | 0.060 |
Why?
|
Blood Coagulation | 2 | 2019 | 1149 | 0.060 |
Why?
|
Whole Blood Coagulation Time | 1 | 2003 | 30 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2015 | 7818 | 0.050 |
Why?
|
Ventricular Function, Left | 1 | 2016 | 3858 | 0.050 |
Why?
|
Blood Urea Nitrogen | 1 | 2003 | 186 | 0.050 |
Why?
|
Vena Cava, Superior | 1 | 2004 | 197 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2014 | 3099 | 0.050 |
Why?
|
Integrins | 2 | 1998 | 836 | 0.050 |
Why?
|
Morbidity | 2 | 2024 | 1754 | 0.050 |
Why?
|
Diuretics | 1 | 2006 | 610 | 0.050 |
Why?
|
North America | 2 | 2019 | 1276 | 0.050 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2002 | 106 | 0.050 |
Why?
|
Cross Infection | 1 | 2011 | 1432 | 0.050 |
Why?
|
Airway Obstruction | 1 | 2007 | 661 | 0.050 |
Why?
|
Medication Errors | 1 | 2008 | 784 | 0.050 |
Why?
|
Venous Thrombosis | 1 | 2011 | 1292 | 0.050 |
Why?
|
Prevalence | 3 | 2015 | 15651 | 0.050 |
Why?
|
Edema | 1 | 2006 | 768 | 0.050 |
Why?
|
Anastomosis, Surgical | 3 | 2015 | 983 | 0.050 |
Why?
|
Combined Modality Therapy | 2 | 2011 | 8530 | 0.050 |
Why?
|
Immunologic Factors | 1 | 2010 | 1585 | 0.050 |
Why?
|
Atrial Flutter | 1 | 2003 | 252 | 0.050 |
Why?
|
Predictive Value of Tests | 3 | 2010 | 15225 | 0.050 |
Why?
|
Tachycardia | 1 | 2003 | 600 | 0.050 |
Why?
|
Alprostadil | 1 | 2021 | 86 | 0.050 |
Why?
|
Aged | 6 | 2022 | 168218 | 0.050 |
Why?
|
Hypotension | 1 | 2007 | 879 | 0.050 |
Why?
|
Neuralgia | 1 | 2007 | 600 | 0.050 |
Why?
|
Factor VIII | 1 | 2003 | 348 | 0.050 |
Why?
|
Embolectomy | 1 | 2021 | 129 | 0.050 |
Why?
|
Radiography, Interventional | 1 | 2008 | 1112 | 0.050 |
Why?
|
Alanine Transaminase | 1 | 2003 | 604 | 0.040 |
Why?
|
Manikins | 2 | 2013 | 242 | 0.040 |
Why?
|
Respiratory Mechanics | 1 | 2004 | 699 | 0.040 |
Why?
|
Intestines | 1 | 2009 | 1906 | 0.040 |
Why?
|
Treatment Failure | 3 | 2015 | 2640 | 0.040 |
Why?
|
Hyperglycemia | 1 | 2008 | 1368 | 0.040 |
Why?
|
Cognition | 1 | 2017 | 6953 | 0.040 |
Why?
|
Prenatal Diagnosis | 1 | 2007 | 1264 | 0.040 |
Why?
|
Anesthesia, General | 1 | 2007 | 1165 | 0.040 |
Why?
|
Hemofiltration | 1 | 2000 | 59 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2023 | 791 | 0.040 |
Why?
|
Respiratory Function Tests | 1 | 2004 | 1680 | 0.040 |
Why?
|
After-Hours Care | 1 | 2020 | 102 | 0.040 |
Why?
|
Pulmonary Veins | 1 | 2005 | 745 | 0.040 |
Why?
|
Perioperative Care | 2 | 2017 | 1028 | 0.040 |
Why?
|
Hemostasis | 1 | 2021 | 466 | 0.040 |
Why?
|
Pregnancy Outcome | 2 | 2010 | 2907 | 0.040 |
Why?
|
Patient Care Team | 1 | 2010 | 2504 | 0.040 |
Why?
|
Thrombelastography | 1 | 2021 | 183 | 0.040 |
Why?
|
Blood Glucose | 2 | 2014 | 6346 | 0.040 |
Why?
|
Thrombocytopenia | 1 | 2006 | 1171 | 0.040 |
Why?
|
Airway Resistance | 1 | 1999 | 400 | 0.040 |
Why?
|
Tyrosine | 2 | 2020 | 1432 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2021 | 58683 | 0.040 |
Why?
|
Graft Rejection | 2 | 2009 | 4426 | 0.040 |
Why?
|
Drug Prescriptions | 1 | 2008 | 1668 | 0.040 |
Why?
|
Dyspnea | 2 | 2018 | 1344 | 0.040 |
Why?
|
Injections, Intravenous | 1 | 2020 | 1378 | 0.040 |
Why?
|
Curriculum | 3 | 2022 | 3717 | 0.040 |
Why?
|
Shock | 1 | 2020 | 314 | 0.040 |
Why?
|
Venous Thromboembolism | 1 | 2011 | 1855 | 0.040 |
Why?
|
Drug Monitoring | 1 | 2024 | 960 | 0.040 |
Why?
|
Comorbidity | 3 | 2020 | 10495 | 0.040 |
Why?
|
Tissue Donors | 2 | 2022 | 2311 | 0.040 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 1998 | 141 | 0.040 |
Why?
|
Pneumococcal Infections | 1 | 2002 | 503 | 0.040 |
Why?
|
Pulmonary Ventilation | 1 | 1999 | 372 | 0.040 |
Why?
|
Sternum | 1 | 2018 | 175 | 0.040 |
Why?
|
Glucocorticoids | 1 | 2007 | 2144 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2017 | 10748 | 0.040 |
Why?
|
Platelet Count | 1 | 2020 | 775 | 0.040 |
Why?
|
Macrophages, Peritoneal | 1 | 1998 | 237 | 0.030 |
Why?
|
Antithrombins | 1 | 2019 | 294 | 0.030 |
Why?
|
Whooping Cough | 1 | 2017 | 85 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2010 | 3867 | 0.030 |
Why?
|
Kidney | 1 | 2011 | 7016 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15399 | 0.030 |
Why?
|
Parenteral Nutrition, Total | 1 | 1997 | 303 | 0.030 |
Why?
|
Heart Massage | 1 | 2015 | 31 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 1998 | 1628 | 0.030 |
Why?
|
Oxyhemoglobins | 1 | 2016 | 212 | 0.030 |
Why?
|
Respiratory Aspiration | 1 | 2017 | 89 | 0.030 |
Why?
|
von Willebrand Factor | 1 | 2019 | 672 | 0.030 |
Why?
|
Equipment Failure | 1 | 1998 | 578 | 0.030 |
Why?
|
Hepatomegaly | 1 | 2015 | 84 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 14641 | 0.030 |
Why?
|
Reoperation | 3 | 2012 | 4282 | 0.030 |
Why?
|
E-Selectin | 1 | 1997 | 576 | 0.030 |
Why?
|
Anxiety | 1 | 2010 | 4539 | 0.030 |
Why?
|
Catecholamines | 1 | 2016 | 385 | 0.030 |
Why?
|
Cardiac Care Facilities | 1 | 2014 | 34 | 0.030 |
Why?
|
Brain Damage, Chronic | 1 | 2015 | 267 | 0.030 |
Why?
|
Vasopressins | 1 | 1996 | 354 | 0.030 |
Why?
|
Cost Control | 1 | 2017 | 628 | 0.030 |
Why?
|
Triiodothyronine | 1 | 2016 | 493 | 0.030 |
Why?
|
Cardiovascular System | 1 | 2022 | 835 | 0.030 |
Why?
|
Streptozocin | 1 | 2014 | 193 | 0.030 |
Why?
|
Immunoglobulins | 1 | 1997 | 859 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1998 | 1125 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2006 | 5098 | 0.030 |
Why?
|
Annual Reports as Topic | 1 | 2013 | 36 | 0.030 |
Why?
|
Arteriosclerosis | 1 | 1998 | 1055 | 0.030 |
Why?
|
History, 20th Century | 1 | 2021 | 2772 | 0.030 |
Why?
|
Adenosine | 1 | 2018 | 802 | 0.030 |
Why?
|
Endocytosis | 1 | 1997 | 958 | 0.030 |
Why?
|
Models, Organizational | 1 | 2016 | 546 | 0.030 |
Why?
|
Analgesics, Opioid | 2 | 2020 | 3765 | 0.030 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2017 | 622 | 0.030 |
Why?
|
Pain | 2 | 2020 | 5065 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3563 | 0.020 |
Why?
|
Apolipoproteins E | 1 | 1998 | 1436 | 0.020 |
Why?
|
Pulmonary Veno-Occlusive Disease | 1 | 2012 | 64 | 0.020 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2017 | 364 | 0.020 |
Why?
|
Stents | 2 | 2015 | 3162 | 0.020 |
Why?
|
Intraoperative Complications | 2 | 2011 | 1184 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2007 | 12951 | 0.020 |
Why?
|
Insurance, Health | 1 | 2024 | 2495 | 0.020 |
Why?
|
Lymphoproliferative Disorders | 1 | 2015 | 533 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2018 | 1386 | 0.020 |
Why?
|
Immunocompromised Host | 1 | 2017 | 856 | 0.020 |
Why?
|
Benzodiazepines | 1 | 2017 | 1130 | 0.020 |
Why?
|
Blood Pressure | 2 | 2023 | 8451 | 0.020 |
Why?
|
Chronic Disease | 2 | 2017 | 9267 | 0.020 |
Why?
|
Rats | 3 | 2016 | 23679 | 0.020 |
Why?
|
Heart Rate | 2 | 2016 | 4166 | 0.020 |
Why?
|
Professional-Family Relations | 1 | 2014 | 495 | 0.020 |
Why?
|
Chile | 1 | 2011 | 255 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2014 | 1844 | 0.020 |
Why?
|
Aspirin | 1 | 2022 | 3131 | 0.020 |
Why?
|
Quality of Health Care | 2 | 2017 | 4317 | 0.020 |
Why?
|
Home Care Services | 1 | 1997 | 647 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 36284 | 0.020 |
Why?
|
Infant, Premature | 2 | 2010 | 2092 | 0.020 |
Why?
|
Abnormalities, Multiple | 2 | 2009 | 1414 | 0.020 |
Why?
|
Withholding Treatment | 1 | 2014 | 610 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2022 | 3671 | 0.020 |
Why?
|
Marfan Syndrome | 1 | 2011 | 236 | 0.020 |
Why?
|
Death | 1 | 2014 | 674 | 0.020 |
Why?
|
Homeostasis | 1 | 2020 | 3301 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2022 | 2359 | 0.020 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2011 | 342 | 0.020 |
Why?
|
Calcium | 1 | 2022 | 5721 | 0.020 |
Why?
|
New York City | 1 | 2011 | 725 | 0.020 |
Why?
|
Hypoglycemic Agents | 2 | 2014 | 3069 | 0.020 |
Why?
|
Group Processes | 1 | 2010 | 226 | 0.020 |
Why?
|
Inflammation | 1 | 2008 | 10718 | 0.020 |
Why?
|
Hemoglobins | 1 | 2014 | 1519 | 0.020 |
Why?
|
Liver Diseases | 1 | 2017 | 1296 | 0.020 |
Why?
|
Oxygen | 1 | 1999 | 4191 | 0.020 |
Why?
|
Islets of Langerhans | 1 | 2014 | 1345 | 0.020 |
Why?
|
Inservice Training | 1 | 2010 | 375 | 0.020 |
Why?
|
Intraoperative Care | 1 | 2011 | 766 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2011 | 1570 | 0.020 |
Why?
|
Sural Nerve | 1 | 2007 | 105 | 0.020 |
Why?
|
Chest Tubes | 1 | 2008 | 152 | 0.020 |
Why?
|
Pancreas | 1 | 2014 | 1676 | 0.020 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2007 | 97 | 0.020 |
Why?
|
Preoperative Period | 1 | 2009 | 553 | 0.020 |
Why?
|
Antigens, CD | 1 | 1998 | 3997 | 0.020 |
Why?
|
Respiratory Tract Diseases | 1 | 2013 | 747 | 0.020 |
Why?
|
California | 1 | 2011 | 1419 | 0.020 |
Why?
|
Insulin | 2 | 2014 | 6578 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2011 | 1829 | 0.020 |
Why?
|
Fatigue | 1 | 2014 | 1542 | 0.020 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2010 | 353 | 0.020 |
Why?
|
Animals | 6 | 2019 | 167768 | 0.020 |
Why?
|
Facial Pain | 1 | 2007 | 120 | 0.020 |
Why?
|
Resource Allocation | 1 | 2009 | 349 | 0.020 |
Why?
|
Antioxidants | 1 | 2014 | 1662 | 0.020 |
Why?
|
Aortic Valve Insufficiency | 1 | 2010 | 578 | 0.020 |
Why?
|
Neural Conduction | 1 | 2007 | 441 | 0.020 |
Why?
|
Task Performance and Analysis | 1 | 2010 | 759 | 0.020 |
Why?
|
Life Tables | 1 | 2006 | 365 | 0.020 |
Why?
|
Methylprednisolone | 1 | 2007 | 384 | 0.020 |
Why?
|
Diuresis | 1 | 2006 | 106 | 0.020 |
Why?
|
Urination | 1 | 2007 | 202 | 0.020 |
Why?
|
Hirudins | 1 | 2006 | 179 | 0.020 |
Why?
|
Heart Septum | 1 | 2006 | 303 | 0.020 |
Why?
|
Immunization, Passive | 1 | 2007 | 616 | 0.020 |
Why?
|
Neurons, Afferent | 1 | 2007 | 498 | 0.020 |
Why?
|
Video Recording | 1 | 2010 | 954 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2016 | 8143 | 0.020 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2010 | 615 | 0.020 |
Why?
|
Neutrophils | 1 | 1997 | 3765 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2007 | 2557 | 0.010 |
Why?
|
Radiography | 1 | 2015 | 6954 | 0.010 |
Why?
|
Thrombin | 1 | 2006 | 590 | 0.010 |
Why?
|
Digestive System Surgical Procedures | 1 | 2009 | 575 | 0.010 |
Why?
|
Peripheral Nerves | 1 | 2007 | 475 | 0.010 |
Why?
|
Fetal Heart | 1 | 2005 | 281 | 0.010 |
Why?
|
Fetal Death | 1 | 2005 | 434 | 0.010 |
Why?
|
Cell Count | 1 | 2007 | 1835 | 0.010 |
Why?
|
Electrodes, Implanted | 1 | 2008 | 833 | 0.010 |
Why?
|
Probability | 1 | 2008 | 2467 | 0.010 |
Why?
|
Recombinant Proteins | 2 | 2006 | 6520 | 0.010 |
Why?
|
Syndrome | 1 | 2009 | 3262 | 0.010 |
Why?
|
Prednisone | 1 | 2007 | 1565 | 0.010 |
Why?
|
Sepsis | 1 | 2017 | 2587 | 0.010 |
Why?
|
Escherichia coli O157 | 1 | 2002 | 53 | 0.010 |
Why?
|
Motor Neurons | 1 | 2007 | 864 | 0.010 |
Why?
|
Autonomic Nervous System | 1 | 2007 | 697 | 0.010 |
Why?
|
Ultrasonography | 2 | 2006 | 5952 | 0.010 |
Why?
|
Drainage | 1 | 2008 | 1161 | 0.010 |
Why?
|
Monitoring, Intraoperative | 1 | 2008 | 939 | 0.010 |
Why?
|
Extremities | 1 | 2007 | 865 | 0.010 |
Why?
|
Program Evaluation | 1 | 2010 | 2492 | 0.010 |
Why?
|
Premature Birth | 1 | 2014 | 1771 | 0.010 |
Why?
|
Constriction, Pathologic | 1 | 2005 | 1097 | 0.010 |
Why?
|
Gastroenteritis | 1 | 2002 | 236 | 0.010 |
Why?
|
Coronary Stenosis | 1 | 2006 | 793 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2010 | 6821 | 0.010 |
Why?
|
Computer Simulation | 1 | 2013 | 6201 | 0.010 |
Why?
|
Dopamine | 1 | 2007 | 1599 | 0.010 |
Why?
|
Emergencies | 1 | 2006 | 1209 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2014 | 3432 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2006 | 2105 | 0.010 |
Why?
|
Hydrocortisone | 1 | 2007 | 1802 | 0.010 |
Why?
|
Patient Admission | 1 | 2006 | 1372 | 0.010 |
Why?
|
Internet | 1 | 2011 | 3082 | 0.010 |
Why?
|
Escherichia coli Infections | 1 | 2002 | 523 | 0.010 |
Why?
|
Asthma | 1 | 2017 | 6172 | 0.010 |
Why?
|
Integrin alpha4 | 1 | 1998 | 87 | 0.010 |
Why?
|
Pneumonia | 1 | 2009 | 2129 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2006 | 6234 | 0.010 |
Why?
|
Ultrasonography, Prenatal | 1 | 2005 | 1745 | 0.010 |
Why?
|
Pain Measurement | 1 | 2007 | 3527 | 0.010 |
Why?
|
Consensus Sequence | 1 | 1997 | 365 | 0.010 |
Why?
|
Streptococcus pneumoniae | 1 | 2002 | 732 | 0.010 |
Why?
|
Massachusetts | 1 | 2009 | 8823 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 2010 | 2942 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2005 | 2131 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2006 | 6293 | 0.010 |
Why?
|
Biopsy | 1 | 2007 | 6768 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2010 | 3992 | 0.010 |
Why?
|
CHO Cells | 1 | 1997 | 1389 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2006 | 4451 | 0.010 |
Why?
|
Signal Transduction | 1 | 1997 | 23342 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1997 | 1693 | 0.010 |
Why?
|
Cricetinae | 1 | 1997 | 2426 | 0.010 |
Why?
|
Skin | 1 | 2007 | 4464 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1997 | 2176 | 0.010 |
Why?
|
Cytoplasm | 1 | 1997 | 1514 | 0.010 |
Why?
|
Echocardiography | 1 | 2005 | 4962 | 0.010 |
Why?
|
Electrocardiography | 1 | 2003 | 6363 | 0.010 |
Why?
|
Kinetics | 1 | 1997 | 6371 | 0.010 |
Why?
|
Transfection | 1 | 1997 | 5779 | 0.010 |
Why?
|
Disease Progression | 1 | 2006 | 13468 | 0.010 |
Why?
|
Neurons | 1 | 2007 | 9416 | 0.000 |
Why?
|
Cell Membrane | 1 | 1997 | 3680 | 0.000 |
Why?
|
Swine | 1 | 1997 | 5892 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1997 | 13447 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1997 | 17617 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 1998 | 9160 | 0.000 |
Why?
|
Mice | 2 | 1998 | 81101 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 1998 | 22003 | 0.000 |
Why?
|